Antioxidant and NMDA Receptor Blocker Wins Anoxic Brain Damage of KorEa OHCA Patients
Status:
Unknown status
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
This study aims to investigate the efficacy and safety of Neu2000KWL, a neuroprotectant, in
patients resuscitated from out-of-hospital cardiac arrest and receiving therapeutic
hypothermia.
Phase:
Phase 2
Details
Lead Sponsor:
GNT Pharma
Collaborators:
Chonnam National University Hospital Gangnam Severance Hospital Kyungpook National University Kyungpook National University Hospital Pusan National University Hospital Samsung Medical Center Soonchunhyang University Hospital